Connections between Metabolism and Epigenetic Modification in MDSCs

Area of Science:

• Immunology
• Cancer Biology
• Metabolic Reprogramming
• Epigenetics

Background:

• Myeloid-derived suppressor cells (MDSCs) are critical immunosuppressive cells within the tumor microenvironment (TME).
• MDSC function is influenced by regulatory factors including metabolic reprogramming, epigenetic modifications, and cell signaling pathways.
• Complex crosstalk exists between these regulatory factors, affecting MDSC development and function.

Purpose of the Study:

• To review the critical roles of metabolism, particularly glucose metabolism, in MDSCs within the TME.
• To summarize significant epigenetic modifications impacting MDSCs in the TME.
• To explore the interplay between metabolism and epigenetic modification in MDSCs and its implications for tumor therapy.

Main Methods:

• Literature review focusing on myeloid-derived suppressor cells (MDSCs).
• Analysis of studies detailing metabolic reprogramming, especially glucose metabolism, in MDSCs.
• Examination of research on epigenetic modifications affecting MDSCs in the tumor microenvironment (TME).

Main Results:

• Metabolic reprogramming, particularly glucose metabolism, significantly shapes MDSC function and immunosuppressive capacity.
• Epigenetic modifications play a crucial role in regulating MDSC differentiation, development, and function.
• The interaction between metabolic and epigenetic pathways in MDSCs influences their overall immunosuppressive effect.

Conclusions:

• Understanding the metabolic and epigenetic landscape of MDSCs in the TME is vital.
• Targeting these interconnected pathways offers potential for developing more effective cancer immunotherapies.
• Further research into the crosstalk between metabolism and epigenetics in MDSCs can identify novel therapeutic strategies.